REFERENCES
1. Kang HJ, Park DY, Kim KH, Song GA, Lauwers GY. Pathologic diagnosis of gastric epithelial neoplasia. Korean J Gastroenterol. 2008; 52:273–280.
2. Abraham SC, Park SJ, Lee JH, Mugartegui L, Wu TT. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol. 2003; 16:786–795.
3. Abraham SC, Montgomery EA, Singh VK, Yardley JH, Wu TT. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol. 2002; 26:1276–1285.
5. Vieth M, Kushima R, Borchard F, Stolte M. Pyloric gland adenoma: a clinicopathological analysis of 90 cases. Virchows Arch. 2003; 442:317–321.
6. Chen ZM, Scudiere JR, Abraham SC, Montgomery E. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol. 2009; 33:186–193.
7. Chung IS, Chung KW, Sun HS, et al. Clinicopathologic evaluation of endoscopic mucosal resection of early gastric carcinomas and gastric adenomas. Korean J Gastroenterol. 1996; 16:15–24.
8. Kushima R, Mü ller W, Stolte M, Borchard F. Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis. Virchows Arch. 1996; 428:223–227.
9. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer. 2006; 9:177–184.
10. Jung CK, Song KY, Park G, et al. Mucin phenotype and CdX2 expression as prognostic factors in gastric carcinomas. Korean J Pathol. 2007; 41:139–148.